-
Celldex Therapeutics Appoints CMO
contractpharma
June 25, 2019
Young brings 30 years of experience leading clinical and cross-functional R&D teams.
-
Symbiosis Boosts Business Development Team to Support US Growth
contractpharma
June 10, 2019
Helen Caddy-Leach to lead the Scottish CMO’s push into the U.S.
-
WuXi AppTec hires cancer drug development vet as new CMO
fiercepharma
April 14, 2019
WuXi AppTec has hired Frederick Hausheer, M.D., as its new chief medical officer as it looks to mine his clinical trial expertise for its boosted drug development offerings.
-
VGXI Achieves Tech Transfer Milestones
contractpharma
March 20, 2019
Relates to RNA manufacturing partnership with research inst. in Houston
-
Terns Pharmaceuticals Announces the Appointment of Chief Medical Officer
americanpharmaceuticalreview
January 21, 2019
Terns Pharmaceuticals announced the appointment of Erin Quirk, M.D. as Chief Medical Officer (CMO). Dr. Quirk brings more than two decades of clinical medicine and drug development experience....
-
DBV CMO leaves as peanut allergy player rejigs team in wake of BLA withdrawal
fiercebiotech
January 07, 2019
Lucia Septién-Velez has stepped down (PDF) as chief medical officer of DBV Technologies. The departure of Septién-Velez is part of a wider reshuffle that gives DBV’s management a new look as it seeks to get its BLA back on track.....
-
Focusing on CRO & CMO Industry Upgrading, Helping Enterprises Seize New Industry Opportunities
en-cphi.cn
December 24, 2018
The emerging CRO & CMO market in Asia-Pacific region is now in the golden period of development, leading the world with the compound annual growth rate of over 20%.
-
Nkarta Appoints SVP & CMO
contractpharma
November 28, 2018
Dr. Rajangam, who will be joining the company in December, is an experienced biotechnology executive with a track record of successfully developing cancer therapies.
-
Evolving World of Pharma: Changing face of the global pharma market: Market Analysis
Sarah Harding
October 10, 2018
As well as driving scientific progress through research and development (R&D), and advancing new therapies that improve the health and quality of life of millions of patients around the world, the pharmaceutical industry is a key asset of the global econo
-
Medivir appoints new CMO
biospectrum
September 12, 2018
Dr. Basse will report to CEO Christine Lind and join the Medivir Executive Team.